X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
c1-inh (72) 72
hereditary angioedema (70) 70
humans (53) 53
immunology (43) 43
index medicus (38) 38
allergy (32) 32
angioneurotic edema (32) 32
male (26) 26
angioedema (25) 25
bradykinin (23) 23
female (23) 23
icatibant (23) 23
c1 inhibitor (21) 21
angioedemas, hereditary - drug therapy (19) 19
complement (18) 18
edema (18) 18
complement c1 inhibitor protein - therapeutic use (17) 17
deficiency (17) 17
adult (16) 16
hae (16) 16
management (16) 16
mutation (15) 15
patients (15) 15
prophylaxis (15) 15
aged (14) 14
ecallantide (14) 14
acquired angioedema (13) 13
attacks (13) 13
diagnosis (13) 13
middle aged (13) 13
analysis (11) 11
c1-inh deficiency (11) 11
esterase inhibitor (11) 11
medicine, general & internal (11) 11
treatment outcome (11) 11
adolescent (10) 10
allergy and immunology (10) 10
angioedema - drug therapy (10) 10
angioedema - genetics (10) 10
c1 esterase inhibitor (10) 10
c1 inhibitor concentrate (10) 10
c1 inhibitor deficiency (10) 10
c1‐inh (10) 10
care and treatment (10) 10
health aspects (10) 10
kallikrein (10) 10
plasma (10) 10
animals (9) 9
biochemistry & molecular biology (9) 9
c1-inhibitor (9) 9
child (9) 9
drug therapy (9) 9
research (9) 9
angioedemas, hereditary - diagnosis (8) 8
angioneurotic-edema (8) 8
c1-inhibitor concentrate (8) 8
c1-inhibitor deficiency (8) 8
complement c1 inactivator proteins - metabolism (8) 8
complement c1 inhibitor protein - adverse effects (8) 8
inhibitor (8) 8
internal medicine (8) 8
long-term prophylaxis (8) 8
studies (8) 8
therapy (8) 8
bradykinin - analogs & derivatives (7) 7
c1-esterase inhibitor (7) 7
c1-inh concentrate (7) 7
complement c1 inhibitor protein (7) 7
self-administration (7) 7
young adult (7) 7
abdomen (6) 6
abdominal pain (6) 6
ace inhibitor (6) 6
acute angioedema (6) 6
angioedema - diagnosis (6) 6
angioedema - immunology (6) 6
berinert (6) 6
complement c1 inactivator proteins - deficiency (6) 6
complement c1 inhibitor protein - administration & dosage (6) 6
concentrate (6) 6
danazol - therapeutic use (6) 6
dermatology (6) 6
medicine (6) 6
medicine & public health (6) 6
pediatrics (6) 6
quality-of-life (6) 6
receptor antagonist (6) 6
recombinant proteins - therapeutic use (6) 6
treatment (6) 6
activation (5) 5
acute attacks (5) 5
angioedemas, hereditary - prevention & control (5) 5
burden (5) 5
complement c1 inactivator proteins - genetics (5) 5
danazol (5) 5
expression (5) 5
family medical history (5) 5
genes (5) 5
immunologic diseases. allergy (5) 5
kallikreins - antagonists & inhibitors (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapeutics and Clinical Risk Management, ISSN 1178-203X, 05/2016, Volume 2016, Issue Issue 1, pp. 701 - 711
Maria Paula Henao,1 Jennifer L Kraschnewski,1 Theodore Kelbel,2 Timothy J Craig3 1Department of Medicine, 2Division of Allergy and Immunology, 3Department of... 
Hereditary angioedema | Angioedema | C1-INH | Abdominal Pain | HAE | C1-INH Deficiency
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2009, Volume 124, Issue 4, pp. 801 - 808
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 02/2011, Volume 9, Issue 2, pp. 99 - 108
Journal Article
Drugs in Context, ISSN 1740-4398, 10/2019, Volume 8, pp. 1 - 11
Hereditary angioedema (HAE) is a rare genetic disorder, characterized by recurrent and unexpected potentially life-threatening mucosal swelling. The impairment... 
C1-inhibitor | hereditary angioedema | lanadelumab | C1-INH | gene therapy | SERPING1 | serine protease | HAE
Journal Article
INFLAMMATION RESEARCH, ISSN 1023-3830, 12/2017, Volume 66, Issue 12, pp. 1107 - 1116
The HIV-1 virus activates the complement system, an essential element of the immune system. SERPING1 is a protease inhibitor that disables C1r/C1s in the C1... 
HIV-1 | SUBFAMILIES | Monocyte | HEREDITARY ANGIOEDEMA | C1-INHIBITOR | Complement | IMMUNOLOGY | DEFICIENCY | CELL BIOLOGY | PANTHER | IFN-gamma | PROTEIN FAMILIES | C1-INH | GENE-EXPRESSION | SERPING1 | INFECTION | INHIBITOR
Journal Article
European Journal of Pediatrics, ISSN 0340-6199, 9/2012, Volume 171, Issue 9, pp. 1339 - 1348
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 06/2018, Volume 186, pp. 73 - 87
Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are... 
Monocytes | Acute myocardial ischemia and reperfusion injury | Dendritic cells | Cytokines | Lymphocytes | Innate immunity | Inflammation | Acute myocardial infarction | Macrophages | Chemokines | ISCHEMIA/REPERFUSION INJURY | MANNOSE-BINDING LECTIN | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | ANTI-C5 COMPLEMENT ANTIBODY | ISCHEMIA-REPERFUSION INJURY | TOLL-LIKE RECEPTOR-2 | PERCUTANEOUS CORONARY INTERVENTION | CARDIOPROTECTIVE THERAPIES CAESAR | REGULATORY T-CELLS | MOBILITY GROUP BOX-1 | PHARMACOLOGY & PHARMACY | Humans | Myocardial Infarction - immunology | Heart Failure - prevention & control | Animals | Myocardial Infarction - drug therapy | Heart Failure - immunology | Inflammation Mediators - metabolism | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Ventricular Remodeling - immunology | Ventricular Remodeling - drug effects | Disease Models, Animal | Transluminal angioplasty | Heart | Fibronectins | Chromosomal proteins | C-reactive protein | Heat shock proteins | Antigen presenting cells | Transforming growth factors | T cells | Biological response modifiers | Heart attack | Prevention | Oligomers | Interleukins | Cardiac patients | Nitric oxide | Bone morphogenetic proteins | Interferon | Health aspects | CCR5, Chemokine receptor 5 | NO, Nitric oxide | EDA, Extra domain A | PMN, Polymorphonuclear leukocytes | AMI, Acute myocardial infarction | MMPs, Matrix metalloproteinases | MCP-1, Monocyte chemoattractant protein-1 | ICAM-1 | Tregs, Regulatory T cells | BAFF, B-cell activating factor | FN-EDA, Fibronectin-end domain A | IFN-γ, Interferon-γ | STEMI, ST segment elevation myocardial infarction | AGEs, Advanced glycation end-products | RAGE, Receptor for advanced glycation end-products | ACS, Acute coronary syndrome | IRF5, Interferon regulatory factor 5 | LTB4, Leukotriene B4 | NLRP3, Nucleotide-binding oligomerization domain-like receptor family of cytosolic proteins | MyD, Myeloid differentiation primary response gene | TLRs, Toll-like receptors | CCL5, Chemokine ligand 5 | CCR2, Chemokine receptor 2 | hs-CRP, High-sensitivity C-reactive protein | DAMPs, Damage-associated molecular patterns | HMGB1, High mobility group box 1 | IHD, Ischemic heart disease | CINC-1, CXCL1, GRO α, KC, Cytokine-induced neutrophil chemoattractant 1 | IL-1, Interleukin-1 | MIP-2α, CXCL2, GRO β, Macrophage inflammatory protein-2α | PS, Phosphatidylserine | CCR9, Chemokine receptor 5 | TNFα, Tumor necrosis factor-alpha | IL-8, CXCL8, Interleukin-8 | MI, Myocardial infarction | PPCI, Primary percutaneous coronary intervention | HSPs, Heat shock proteins | LV, Left ventricular | CR1, Complement receptor 1 | eRNA, Extracellular ribonucleic acids | CCL2, Chemokine ligand 2 | NF-κB, Nuclear factor kappa-light-chain-enhancer of activated B cells | TGF-β, Transforming growth factor-β | ROS, Reactive oxygen species | ICAM-2, Intercellular adhesion molecule | ECM, Extracellular matrix | C1-INH, C1-inhibitor | NLRs, NOD-like receptors | PRRs, Pattern recognition receptors
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 2004, Volume 114, Issue 3, pp. S51 - S131
Journal Article